Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Lercanidipine Hydrochloride with Related Impurities
International Journal of Drug Delivery Technology · 01.06.2026 · 16 (41s)
DOI: 10.25258/ijddt.16.41s.67 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 01.06.2026. Verfasst von Jiten Mishra und 6 weiteren Autor:innen.
Abstract (Originalsprache)
The present investigation describes the systematic development and rigorous validation of a stability-indicating reversedphase high-performance liquid chromatographic (RP-HPLC) method for the simultaneous quantitative determination of enalapril maleate (ENP) and lercanidipine hydrochloride (LER), along with their principal related impurities — enalaprilat (Impurity A) and diketopiperazine derivative (Impurity B) — in pharmaceutical fixed-dose combination formulations. The primary objective was to demonstrate the stability-indicating capacity and analytical reliability of the developed method in conformance with the International Council for Harmonization (ICH) guideline Q2(R2) for validation of analytical procedures. Chromatographic separation was achieved on an Agilent Zorbax SB-C18 column (250 × 4.6 mm, 5 µm particle size) maintained at 30 ± 0.5°C, using a binary gradient mobile phase consisting of 10 mM ammonium dihydrogen phosphate buffer (pH 3.2 ± 0.05) and acetonitrile (35:65 v/v) at a flow rate of 1.0 mL/min. Detection was performed using a photodiode array (PDA) detector at 215 nm with an injection volume of 10 µL. Forced degradation studies encompassing acidic, alkaline, oxidative, thermal, photolytic, and humid heat conditions were conducted to establish the stabilityindicating nature of the method. Validation was performed for specificity, linearity, accuracy, precision (intra-day and inter-day), limits of detection and quantification, and robustness in strict accordance with ICH Q2(R2) requirements. Complete baseline resolution of ENP (tR = 4.82 min), LER (tR = 9.47 min), Imp. A (tR = 3.15 min), and Imp. B (tR = 6.28 min) was achieved within 12 minutes, with resolution values exceeding 4.0 between all adjacent pairs. Calibration curves demonstrated excellent linearity over concentration ranges of 2.5–75.0 µg/mL for ENP and 1.0–30.0 µg/mL for LER (r² ≥ 0.9997). Accuracy (% recovery: 99.70–99.92%), precision (%RSD < 0.84%), LOD (0.009–0.082 µg/mL), and LOQ (0.028–0.248 µg/mL) were well within acceptable ICH limits. All degradation products were chromatographically resolved from the analyte peaks, affirming the stability-indicating power of the method. The validated RP-HPLC method is precise, accurate, sensitive, robust, and stability-indicating. It is suitable for routine quality control analysis, impurity profiling, and stability testing of ENP-LER fixed-dose combination products. The method's compliance with ICH Q2(R2) parameters and its successful application to the marketed formulation render it a valuable analytical tool for pharmaceutical quality assurance.
Zitieren
APA
Mishra, J., Gopalakrishnan, R., Srivastav, S., Awasthi, D., Hussainaiah, D., Dash, B., & Chougule, V. G. (2026). Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Lercanidipine Hydrochloride with Related Impurities. International Journal of Drug Delivery Technology, 16(41s). https://doi.org/10.25258/ijddt.16.41s.67
Vancouver
Mishra J, Gopalakrishnan R, Srivastav S, Awasthi D, Hussainaiah D, Dash B, et al. Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Lercanidipine Hydrochloride with Related Impurities. International Journal of Drug Delivery Technology. 2026;16(41s). doi:10.25258/ijddt.16.41s.67
BibTeX
@article{Mishra2026,
author = {Mishra, Jiten and Gopalakrishnan, Reshmi and Srivastav, Shruti and Awasthi, Deepak and Hussainaiah, Dudekula and Dash, Biswajit and Chougule, Venkat Gangadhar},
title = {Development and Validation of a Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enalapril Maleate and Lercanidipine Hydrochloride with Related Impurities},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {41s},
doi = {10.25258/ijddt.16.41s.67}
}
EUVIMED